In a subset of patients presenting with thyroid storm, standard antithyroid drug (ATD) therapy is not viable — either because the patient has developed severe adverse effects from antithyroid drugs, carries a known allergy to antithyroid drugs, or has an established allergy to inorganic iodide-containing drugs.
Each of these constraints narrows the treatment landscape considerably and requires an alternative strategy to achieve the primary clinical goal: rapid reduction in circulating thyroid hormone levels.
When ATDs can no longer be used because of severe adverse effects, the enterohepatic circulation of thyroid hormones — which is heightened in hyperthyroidism — becomes a key physiological target for alternative interventions. Patients with allergy to inorganic iodide-containing drugs face an additional constraint, as iodide-based measures typically employed in thyroid storm are contraindicated or require exceptional caution.
The protocol addresses this population with agents that bypass ATD pathways entirely. One approach uses a binding resin that acts on the enterohepatic circulation of thyroid hormones; a separate agent from a different pharmacological class is available for patients where iodide allergy is the driving contraindication.
Full regimen details, sequencing, monitoring requirements, and dosing are available in the structured protocol below.Reduction in circulating thyroid hormone levels.
When ATDs can no longer be used because of severe adverse effects, binding resins such as cholestyramine, which binds iodothyronine, are an adjunctive measure to physically remove thyroid hormones from the enterohepatic circulation, which is increased in hyperthyroidism.
Lithium may be used in patients allergic to ATDs or iodide to reduce circulating thyroid hormone levels, though serum lithium levels should be monitored to avoid toxicity.
However, patients who are known to be allergic to inorganic iodide-containing drugs should not be given KI, though if they are they should be monitored carefully.
The dose of cholestyramine for effectively reducing thyroid hormone levels has been recommended to be 4 g three or four times daily.
View source ↗